Influence of bedside blood insulin measurement on acute coronary syndrome pathways

Critical Pathways in Cardiology

Volumn 10, Issue 4, 2011, Pages 185-188

  Panza Nduli, José ^a   Coulic, Very ^a   Willems, Dominique ^a   Devriendt, Jacques ^a   Gottignies, Philippe ^a   Staroukine, Michel ^a   De Bels, David ^a  

^a BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

acute coronary syndrome; coronary artery disease; critical pathways; diabetes; insulin; percutaneous coronary intervention

Indexed keywords

HEMOGLOBIN A1C; INSULIN; TROPONIN T;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOT LYSIS; CORONARY ARTERY BLOOD FLOW; DISEASE SEVERITY; ECHOCARDIOGRAPHY; EMERGENCY WARD; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; INSULIN BLOOD LEVEL; LABORATORY TEST; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; ST SEGMENT;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; BIOLOGICAL MARKERS; COMORBIDITY; CORONARY CARE UNITS; CRITICAL PATHWAYS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS;

EID: 81755166779     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e318238c5ca     Document Type: Article

References (18)

1. Vanhorebeek I, Langouche L, Van den Berghe G. Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness? Curr Opin Crit Care. 2005;11:304-311. (Pubitemid 41248301)
2. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359-1367.
3. Tsang MW, Davidoff R, Korach A, et al. Diastolic dysfunction after coronary artery bypass grafting-the effect of glucose-insulin-potassium infusion. J Card Surg. 2007;22:185-191. (Pubitemid 46683939)
4. Aguilar D, Solomon SD, Kober L, et al. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Circulation. 2004;110:1572-1578. (Pubitemid 39297978)
5. Stochmal E, Szurkowska M, Czarnecka D, et al. Association of coronary atherosclerosis with insulin resistance in patients with impaired glucose tolerance. Acta Cardiol. 2005;60:325-331. (Pubitemid 40827243)
6. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461. (Pubitemid 43200296)
7. Bucciarelli-Ducci C, Bianchi M, De Luca L, et al. Effects of glucose-insulinpotassium infusion on myocardial perfusion and left ventricular remodeling in patients treated with primary angioplasty for ST-elevation acute myocardial infarction. Am J Cardiol. 2006;98:1349-1353. (Pubitemid 44666637)
8. Finfer S, Chittock DR, Su SY, et al. NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360:1283-1297.
9. The TIMI Study Group. The thrombolysis in myocardial infarction (TIMI) trial: phase I findings. N Engl J Med. 1984;33:523-530.
10. Bensouda C, Otel I, Danchin N. Clinical aspects of acute coronary syndromes in French. Med Sci (Paris). 2004;20:402-407. (Pubitemid 38480591)
11. Wallander M, Bartnik M, Efendic S, et al. Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia. 2005;48:2229-2235. (Pubitemid 41618911)
12. Kowalska I, Prokop J, Bachorzewska-Gajewska H, et al. Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as predictor for coronary atherosclerosis. Diabetes Care. 2001;24: 897-901. (Pubitemid 33636066)
13. Das UN. Insulin: an endogenous cardioprotector. Curr Opin Crit Care. 2003;9:375-383. (Pubitemid 37204792)
14. Hashimoto K, Ikewaki K, Yagi H, et al. Glucose intolerance is common in Japanese patients with acute coronary syndrome who were not previously diagnosed with diabetes. Diabetes Care. 2005;28:1182-1186. (Pubitemid 40616632)
15. Diaz R, Goyal A, Mehta SR, et al. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. JAMA. 2007;298: 2399-2405. (Pubitemid 350190781)
16. Kushner FG, Hand M, Smith SC Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;54:2205-2241.
17. Neumann FJ, Kastrati A, Pogatsa-Murray G, et al. Evaluation of prolonged antithrombotic pretreatment ("cooling-off" strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial. JAMA. 2003;290:1593-1599. (Pubitemid 37441261)
18. Wright RS, Anderson JL, Adams CD, et al. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in Collaboration With the American Academy of Family Physicians, Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2011;57:e215-e367.